TY - JOUR
T1 - Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation
T2 - Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
AU - Ifversen, Marianne
AU - Meisel, Roland
AU - Sedlacek, Petr
AU - Kalwak, Krzysztof
AU - Sisinni, Luisa
AU - Hutt, Daphna
AU - Lehrnbecher, Thomas
AU - Balduzzi, Adriana
AU - Diesch, Tamara
AU - Jarisch, Andrea
AU - Güngör, Tayfun
AU - Stein, Jerry
AU - Yaniv, Isaac
AU - Bonig, Halvard
AU - Kuhlen, Michaela
AU - Ansari, Marc
AU - Nava, Tiago
AU - Dalle, Jean Hugues
AU - Diaz-de-Heredia, Cristina
AU - Trigoso, Eugenia
AU - Falkenberg, Ulrike
AU - Hartmann, Mihaela
AU - Deiana, Marco
AU - Canesi, Marta
AU - Broggi, Chiara
AU - Bertaina, Alice
AU - Gibson, Brenda
AU - Krivan, Gergely
AU - Vettenranta, Kim
AU - Matic, Toni
AU - Buechner, Jochen
AU - Lawitschka, Anita
AU - Peters, Christina
AU - Yesilipek, Akif
AU - Yalçin, Koray
AU - Lucchini, Giovanna
AU - Bakhtiar, Shahrzad
AU - Turkiewicz, Dominik
AU - Niinimäki, Riitta
AU - Wachowiak, Jacek
AU - Cesaro, Simone
AU - Dalissier, Arnaud
AU - Corbacioglu, Selim
AU - Willasch, Andre Manfred
AU - Bader, Peter
N1 - Publisher Copyright:
© Copyright © 2021 Ifversen, Meisel, Sedlacek, Kalwak, Sisinni, Hutt, Lehrnbecher, Balduzzi, Diesch, Jarisch, Güngör, Stein, Yaniv, Bonig, Kuhlen, Ansari, Nava, Dalle, Diaz-de-Heredia, Trigoso, Falkenberg, Hartmann, Deiana, Canesi, Broggi, Bertaina, Gibson, Krivan, Vettenranta, Matic, Buechner, Lawitschka, Peters, Yesilipek, Yalçin, Lucchini, Bakhtiar, Turkiewicz, Niinimäki, Wachowiak, Cesaro, Dalissier, Corbacioglu, Willasch and Bader.
PY - 2021/7/29
Y1 - 2021/7/29
N2 - Specific protocols define eligibility, conditioning, donor selection, graft composition and prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic stem cell transplant (HSCT). However, international protocols rarely, if ever, detail supportive care, including pharmaceutical infection prophylaxis, physical protection with face masks and cohort isolation or food restrictions. Supportive care suffers from a lack of scientific evidence and implementation of practices in the transplant centers brings extensive restrictions to the child's and family's daily life after HSCT. Therefore, the Board of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) held a series of dedicated workshops since 2017 with the aim of initiating the production of a set of minimal recommendations. The present paper describes the consensus reached within the field of infection prophylaxis.
AB - Specific protocols define eligibility, conditioning, donor selection, graft composition and prophylaxis of graft vs. host disease for children and young adults undergoing hematopoietic stem cell transplant (HSCT). However, international protocols rarely, if ever, detail supportive care, including pharmaceutical infection prophylaxis, physical protection with face masks and cohort isolation or food restrictions. Supportive care suffers from a lack of scientific evidence and implementation of practices in the transplant centers brings extensive restrictions to the child's and family's daily life after HSCT. Therefore, the Board of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) held a series of dedicated workshops since 2017 with the aim of initiating the production of a set of minimal recommendations. The present paper describes the consensus reached within the field of infection prophylaxis.
KW - allogeneic hematological stem cell transplantation
KW - antibiotic prophylactic therapy
KW - children
KW - infection precaution
KW - vaccination
UR - http://www.scopus.com/inward/record.url?scp=85112474969&partnerID=8YFLogxK
U2 - 10.3389/fped.2021.705179
DO - 10.3389/fped.2021.705179
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34395344
AN - SCOPUS:85112474969
SN - 2296-2360
VL - 9
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
M1 - 705179
ER -